Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
The aim of this tender is to establish preferred and CPI approved suppliers for the Hub molecule, for use by CPI in pilot-scale manufacturing of oligonucleotides at the MMIC site near Glasgow. The material will be used in the manufacture of materials going into clinical trials, therefore supplier approvals will be required.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Xiamen Sinopeg Biotech | - | £1,000,000 | - |